ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
2
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,915
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Sunitinib in thymic carcinoma: enigmas still unresolved
Author(s):
Alexander Marx
,
Cleo-Aron Weis
Publication date
Created:
February 2015
Publication date
(Print):
February 2015
Journal:
The Lancet Oncology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ScienceOpen Research
Author and article information
Journal
Title:
The Lancet Oncology
Abbreviated Title:
The Lancet Oncology
Publisher:
Elsevier BV
ISSN (Print):
14702045
Publication date Created:
February 2015
Publication date (Print):
February 2015
Volume
: 16
Issue
: 2
Pages
: 124-125
Article
DOI:
10.1016/S1470-2045(15)70010-0
SO-VID:
3538d6fc-ba80-47ee-b440-aa43d312761b
Copyright ©
© 2015
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,915
The enigma of inhaled salbutamol and sport: unresolved after 45 years
Authors:
Ken Fitch
SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer.
Authors:
E.L. Mayer
,
S Dhakil
,
T. Patel
…
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Authors:
Victor Priego
,
Denise A Yardley
,
Dianna L Shipley
…
See all similar
Cited by
1
TFE3‐PD‐L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma
Authors:
Xudong Guo
,
Ruxia Li
,
Qiulei Bai
…
See all cited by